Pfizer (PFE) is a leading global provider of anti-infective medicines, offering patients access to a diverse portfolio of more than 80 products.
Reportedly, Pfizer is investing $500 million in Sanford, North Carolina to expand the manufacturing facility for gene therapy. The investment to add additional capacity to the facility for Pfizer’s experimental treatments for late-stage Duchenne Muscular Dystrophy (DMD) and hemophilia B therapies among other gene therapies. Pfizer is seeking to be the first to bring a curative, late-stage treatment to DMD market.
Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.
Stay Informed! Stay Competitive!